A Transporter Associated with Antigen-Processing Independent Vacuolar Pathway for the MHC Class I-Mediated Presentation of Endogenous Transmembrane Proteins
Neeraj Tiwari, 1 
tapasin
Ϫ/Ϫ C57BL/6 mice (22), respectively. K b -transfected P815 mastocytoma cells were from B. Arnold (German Cancer Research Center, Heidelberg, Germany). Ltk Ϫ is a fibroblast line (H-2 k ). TAP-deficient RMA-S T lymphoma cells (H-2 b ) have been described (23) . RMA cells (H-2 b ) expressing OVA in the cytoplasm were a gift from L. Eisenbach (Weizman Institute, Rehovot, Israel). Mouse embryonal fibroblast lines (H-2 bϩ ) derived from cathepsin B Ϫ/Ϫ and cathepsin D Ϫ/Ϫ mice have been described (24) .
Abs and Western blots
The K b -and K d -specific mAbs Y3 and 15.5.5S have been described (25, 26) . mAb 25.D1-16, provided by R. Germain (National Institutes of Health, Bethesda, MD), recognizes K b molecules complexed with SIINFEKL peptide (27) . The anti-His 6 mAb 13/45/31a and the anti-flag mAb 4E11-18 were gifts from H. Zentgraf (German Cancer Research Center, Heidelberg, Germany). Rabbit polyclonal Ab specific for mouse TAP2 (mTAP2.688) (22) has been described. Rabbit anti-mouse tapasin antiserum 2668 was donated by T. Hansen (Washington University, St. Louis, MO). Rabbit anti-mouse ERAP1 polyclonal Ab was raised against the N-terminal keyhole limpet hemocyanin-coupled ERAP1 peptide QNSDIESLKASNGC by Eurogentec. Western blot analyses of ERAP1-transfected cells as well as TAP1
Ϫ/Ϫ and tapasin Ϫ/Ϫ fibroblasts were performed exactly as described (22, 28) . Rabbit anti-EEA-1 and rat anti-LAMP-1 polyclonal Abs were from BD Biosciences. Anti-CD63 mAb C2418-09 was from USBiological. Rabbit anti-vesicle-associated membrane protein 8 (VAMP-8) has been described (29) . A rabbit antiserum specific for the 270-kDa mannose-6-phosphate receptor (M6PR) was a gift from K. von Figura (University of Göttingen, Göttingen, Germany). Cy5-coupled goat anti-mouse IgG, Cy3-coupled goat anti-rabbit, goat anti-rat or goat anti-mouse IgG, and tetramethylrhodamine isothiocyanate-coupled goat anti-rabbit IgG secondary Abs were from Dianova.
DNA plasmids
Plasmids encoding K b , K d , and OVA cDNAs were provided by B. Arnold (German Cancer Research Center, Heidelberg, Germany) and Y. Reiss (Tel Aviv University, Tel Aviv, Israel). cDNAs coding for peptide-MHC-I fusion proteins were assembled stepwise in pBluescript KS II ϩ (Stratagene) using conventional PCR techniques and insertion of double-stranded oligonucleotides digested with appropriate restriction enzymes. Completed constructs were subcloned into the expression vector pcDNA3.1(ϩ) (Invitrogen Life Technologies). A modified influenza virus HA1 leader sequence (MAKANLLVLLCALAAADA) was used to target the fusion proteins into the ER. This leader was followed by sequences coding for SIINFEKL, LX-SIINFEKL (with X being E, R, Y, F, Q, H, I, or P), OVA(V 249 -E 256 )-SIINFEKL, OVA(V 120 -E 256 )-SIINFEKL, RKKR-SIINFEKL, LCRKKR-SIINFEKL, and DYKDDDDKA-SIINFEKL, respectively. The linker FLG 4 SG 4 APGSG 3 S (sp19) was positioned between SIINFEKL and cDNA sequences encoding mature K b or K d . To study the influence of the Cterminal flank on processing, the residues FL in sp19 were replaced by DL, GL, RL, VL, PL, GG, and PG, respectively. Cytoplasmic tail point mutants of K b (Y321P; T329A/S330A/S333A) and K d (Y320P; T328A/S329A/ S332A) and truncated tails of K b/d (residual tail sequence RRRNTGG) were generated by PCR using reverse primers containing the mentioned mutations or a premature stop codon, respectively. To generate K b and K d fusion proteins tagged at the truncated cytoplasmic tail with enhanced GFP (EGFP), cDNAs containing an EcoRI site inserted 3Ј of RRRNTGG were ligated into the multicloning site of pEGFP-N1 (BD Biosciences). To generate His-tagged K b fusion proteins, the blunted BspHI site (at residue H361) was ligated onto the Eco32I site in pcDNA6-V5/HisA (Invitrogen Life Technologies). A mouse ERAP1 cDNA clone was obtained from the German Resource Center for Genome Research. All constructs were confirmed by sequencing.
Transfections
Stable transfections of P185 and RMA-S cells were done by electroporation of 10 7 cells with 10 g of plasmid DNA using the Bio-Rad GenePulser (220 V, 960 F) and selection with 0.8 -1.0 mg/ml geneticin (SigmaAldrich 
T cell assays
The lacZ-inducible T cell hybridoma B3Z recognizing K b molecules loaded with SIINFEKL peptide was a gift from N. Shastri (University of California, Berkeley, CA) (30) . A total of 5 ϫ 10 4 B3Z cells was cocultured with 10 4 stably or transiently transfected cells for 18 h at 37°C. The Ag-specific stimulation of B3Z was determined by addition of lacZ substrate buffer (9 mM MgCl 2 , 0.15 mM CPRG, 100 mM 2-ME, 0.125% Nonidet P-40 in PBS (pH 7.5)) for 4 h at 37°C. The cleaved CPRG was measured in an ELISA reader as absorbance at 595 nm with 630 nm as the reference wavelength. The data are shown as means of triplicate values and SEM from representative examples of two to four similar experiments. To remove pre-existing MHC-I-peptide complexes from the cell surface, APCs were preincubated in the presence of various inhibitors for 1 h, washed once in PBS, and incubated in acid wash buffer at pH 3.0 (39.8 ml of 0.1 M citric acid/10.2 ml of 0.2 M Na 2 HPO 4 /50 ml of water) for 3 min, followed by three washes in DMEM supplemented with 10% FCS. After acid stripping, the cells were allowed to recover in the presence of the same concentrations of inhibitors for 6 -14 h. Subsequently, cells were washed in PBS and fixed in 0.05% glutaraldehyde in ice-cold Dulbecco's PBS (D-PBS) for 4 min. The fixative was quenched with 200 mM glycine in PBS for 30 s, followed by two washes in PBS, two washes in complete DMEM, and addition of B3Z cells.
Enzyme inhibition assays
To assess the inhibition of cell-expressed furin by the furin inhibitor decanoyl-RVKR-CMK, 10 6 MCB6TAP Ϫ/Ϫ cells per sample were pretreated with 100 M furin inhibitor or DMSO for 14 h, followed by homogenization in 50 mM Na acetate (pH 7.0)/5 mM CaCl 2 using a Potter homogenizer and centrifugation at 15,000 ϫ g for 10 min at 4°C. Triplicate samples of 100 l of supernatant were reconstituted with 100 M furin inhibitor or DMSO for control. Then 100 M furin substrate Boc-RVRR-AMC was added for 4 h at room temperature. The reaction was stopped by addition of 50 l of acetic acid. Samples were analyzed in a SpectraMax Gemini XS spectrometer (Molecular Devices) using 380 nm excitation and 525 nm emission wavelengths.
To assess the inhibition of autophagy by the phosphoinositide 3-kinase inhibitors wortmannin and 3-methyladenine, a dansylcadaverine uptake assay was performed essentially as described (31) . MCB6TAP
Ϫ/Ϫ cells (3.5 ϫ 10 5 /sample) were pretreated with 1.5 M wortmannin or 7.5 mM 3-methyladenine for 3 h, followed by three washes in D-PBS. To induce starvation, samples were then incubated in D-PBS for 4 h at 37°C, or DMEM/10% FCS medium for control. Dansylcadaverine (50 M) was added for 15 min at 37°C. After four washes in D-PBS, the cell pellets were lysed in 250 l of TBS (pH 8.0)/0.1% Nonidet P-40. Lysates were analyzed in a SpectraMax Gemini XS spectrometer using 380-nm excitation and 525-nm emission wavelengths.
Immunofluorescence stainings
Flow cytometry of transfected cells was performed as described previously (28) . For confocal immunofluorescence microscopy, transiently transfected MCB6TAP Ϫ/Ϫ cells were seeded in 48-well plates on coverslips coated with 0.1% (w/v) poly-L-lysine. Cells were fixed for 10 min in fixation buffer (4% paraformaldehyde in 150 mM NaCl, 200 mM HEPES (pH 7.4)) on ice, followed by two washes in 200 mM glycine buffer for 2 min. Fixed cells were permeabilized and blocked using PBS (pH 7.4) supplemented with 0.1% saponin (Sigma-Aldrich) and 7% horse serum for 1 h at room temperature. Primary Abs were diluted in 250 l of PBS/saponin and incubated with the cells overnight at 4°C. After three washes in PBS/saponin, second Abs were added in 250 l for 30 min at room temperature, followed by three washes and mounting. Immunofluorescence stainings were analyzed by confocal laser-scanning microscopy (LSM 510; Zeiss). Costaining coefficients were obtained from the analysis of 8 -10 cells using LSM Image Examiner software.
Results

TAP-independent presentation of MHC-I-derived fusion proteins
The ectodomain of MHC-I molecules itself is known to harbor peptide epitopes presented by a variety of MHC-I allomorphs. We therefore used modified MHC-I H chains to study the TAP-independent processing and presentation of endogenous transmembrane proteins. The K b -restricted OVA epitope SIINFEKL (SL8), or N-terminally extended versions of SL8, were fused through a linker sequence to the N-terminal end of the ectodomains of K b and K d H chains (Fig. 1A) . This strategy targeted the epitopecarrying sequence to the ER lumen and excluded a contribution of cytosolic proteases to epitope processing when the fusion proteins were expressed in TAP-deficient cells.
TAP-deficient MCB6TAP Ϫ/Ϫ fibroblasts were transfected to express SL8-K b fusion proteins containing N-terminal extensions derived from the natural OVA protein or appended by the sequences RKKR (a potential furin cleavage site), DYKDDDDKA ( flag-tag), and GPDYKDDDDKA (GP-flag), respectively (Fig. 1B) . The SL8/ K b -specific T cell hybridoma B3Z recognized all transfectants, albeit with varying efficiencies. Consistent with earlier reports (30, 32), we found that B3Z T cells recognized N-or C-terminally peptide analogues of the SL8 epitope ϳ3 orders of magnitude less Ϫ/Ϫ cells that were transiently transfected with the indicated peptide-K b fusion proteins containing variations in N-terminal (G) or C-terminal (H) amino acids, respectively, flanking the SL8 epitope. Expression of the fusion proteins was monitored by Western blot using an His 6 -tag-specific mAb. Ϫ, no N-terminal extension.
efficiently than SL8 itself, and were unresponsive to biterminally extended SL8 (Fig. 1C) . The stimulation of B3Z by K b fusions containing SL8 embedded within N-and C-terminal flanking sequences thus indicated proteolytic processing of the fusion proteins and final trimming of the SL8 epitope. The presentation of exogenous SL8 peptide and transfected fusion proteins by Filipin complex (10 g/ml) 10 g/ml chlorpromazine, or DMSO for control were added during a 11-h recovery period, followed by fixation and coculture with B3Z. D, Acid wash recovery experiments as in A. CHX (50 M) (CHX chase) or DMSO for control was added during a 11-h recovery period, followed by fixation and coculture with B3Z. For control of the function
MCB6TAP
Ϫ/Ϫ cells was titrated in Fig. 1D . The 0. 1E) . In contrast to these membrane-bound endogenous Ags, exogenous OVA protein offered at a high concentration (12.5 mg/ml for 24 h) was poorly cross-presented. Likewise, TAP-deficient RMA-S T lymphoma cells presented the SL8-K d conjugate, but did not significantly cross-present OVA protein (Fig. 1F) . To study the effect of flanking residues on epitope processing, fusion proteins with the consensus sequences LX-SL8-sp19-K b and RKKR-SL8-XL/G-sp17-K b were expressed in MCB6TAP Ϫ/Ϫ fibroblasts. Various charged, polar and hydrophobic amino acids were tolerated as N-terminal (Fig. 1G ) and C-terminal flanks (Fig. 1H) . Major quantitative differences were noted, however, with B3Z responses being significantly reduced when a proline residue was located N-or Cterminally adjacent to the SL8 sequence. Using cells from the same transient transfections, similar expression levels of the different fusion proteins were monitored by Western blots detecting a hexa-histidine tag attached to the cytoplasmic tail of K b fusion proteins.
Evidence for involvement of furin, but not ERAP1 in fusion protein processing
TAP-deficient MCB6TAP
Ϫ/Ϫ cells still express tapasin ( Fig. 2A ) and can therefore build up a partial peptide-loading complex that might modulate the expression of TAP-independent MHC-I peptide complexes (28, 33) . To study a potential role of tapasin, we used the tapasin Ϫ/Ϫ fibroblast line MC4 that also completely lacks TAP2 expression ( Fig. 2A) , which is most likely due to the lack of TAP stabilization in the absence of tapasin (22, 28) . MC4 cells presented, however, N-terminally extended SL8 fusion proteins with no apparent defect as compared with MCB6TAP Ϫ/Ϫ , suggesting that tapasin played no specific role in fusion protein trafficking and processing. Next, we analyzed a potential role of the ER aminopeptidase ERAP1, which disfavors trimming of substrates with proline at position 2 (34). Down-modulation of ERAP1 by siRNA transfection of MC4 cells left the B3Z responses to SL8 fusion proteins either unaltered or slightly enhanced their presentation (Fig. 2B) . Overexpression of ERAP1 in MCB6TAP Ϫ/Ϫ cells did not influence fusion protein presentation (Fig. 2C) . For control of the mouse ERAP1 cDNA, TAP-proficient RMA cells expressing cytoplasmic OVA were supertransfected with mouse ERAP1. SL8 presentation was enhanced, suggesting improved peptide trimming in the presence of overexpressed ERAP1, whereas the aminopeptidase inhibitor leucine thiol (34) blocked this enhancement (Fig. 2D) . The endoprotease furin, which cleaves proproteins at the C-terminal end of RXXR motifs, was described to be involved in Ag processing in the secretory pathway (20) . After an acid wash to remove pre-existing SL8:K b complexes, transfected MCB6TAP
Ϫ/Ϫ cells were treated with the furin inhibitor Dec-RVKR-CMK. This treatment significantly reduced the presentation of fusion proteins carrying the N-terminal extensions RKKR and LCRKKR, but did not affect the presentation of the SL8-, LE-SL8-, and RKNKTR-SL8-K b chimeras (Fig.  2E) . In parallel, we assessed the capacity of Dec-RVKR-CMK to block cell-borne furin. Inhibitor-treated or control MCB6TAP Ϫ/Ϫ cells were homogenized, and residual furin activity was determined using a fluorogenic substrate. Furin activity was found to be largely inhibited (Fig. 2E) . Thus, depending on the sequence context, the TGN protease furin appeared to contribute to processing of the SL8 epitope.
Fusion proteins are internalized from the cell surface and processed in a pH-dependent manner
To analyze whether autophagy of ER-derived vesicles was involved in fusion protein, we used the PI3K inhibitors, 3-methyladenine and wortmannin, which block the autophagy response. In acid wash/reappearance assays, these inhibitors had no reducing effect (Fig. 3A) . To control for the autophagy blocking effect of wortmannin and 3-methyladenine, we performed a dansylcadaverine accumulation assay (31) . After starvation in saline, MCB6TAP
Ϫ/Ϫ cells showed an increased uptake of dansylcadaverine, which was inhibited by the PI3K inhibitors (Fig. 3A) . These experiments argue against a significant contribution of autophagy to fusion protein processing.
Because transfected peptide-K d/b fusion proteins were detectable on the cell surface of MCB6TAP Ϫ/Ϫ and RMA-S cells by cytofluorometry (Fig. 3B) , it was conceivable that they underwent internalization from the plasma membrane into endolysosomal vesicles for processing. To explore this possibility, we used the sterol-binding agent filipin as well as the cationic amphiphilic compound chlorpromazine to block the clathrin-independent and -dependent internalization pathways, respectively (35, 36) . In acid wash/reappearance assays, both chlorpromazine and filipin significantly inhibited the presentation of (RKKR)SL8-K d and K b fusion proteins, indicating that clathrin-dependent as well as clathrin-independent internalization preceded processing (Fig. 3C) . The protein synthesis inhibitor cycloheximide (CHX) did not affect presentation in reappearance assays, whereas CHX suppressed the de novo expression and presentation of peptide-MHC-I fusion proteins when present during the transfection period (Fig. 3D ). This finding suggested that epitope processing and formation of SL8:K b complexes were independent of newly synthesized fusion protein emerging out of the ER during the reappearance period, but rather relied on pre-existing molecules.
The presentation of K b and K d fusion proteins was substantially inhibited when transfected MCB6TAP Ϫ/Ϫ or RMA-S cells were allowed to recover in the presence of the acidophilic amines, chloroquine and primaquine, as well as the inhibitors of the V-type H ϩ -ATPase, bafilomycin A 1 and folimycin. Because these pHneutralizing compounds interfere with the function of endolysosomal hydrolases, the results suggest that the fusion proteins underwent processing in acidic endosomal compartments (Fig. 3, E, top  panel, and F) . In addition to increasing endosomal pH, primaquine could have interfered with the recycling of peptide-loaded MHC-I molecules from endosomes to the cell surface (37) . 
MCB6TAP
Ϫ/Ϫ cells were acid denatured, treated with pH-neutralizing compounds, and incubated with synthetic SL8 peptide before fixation. The capacity of MCB6TAP Ϫ/Ϫ cells to present exogenous SL8 peptide remained unimpaired (Fig. 3E, bottom panel) , suggesting that the reappearance of peptide-receptive K b molecules was not affected by the inhibitors, including primaquine.
The endosomal processing pathway is also used by TAP-proficient cells
To investigate the question whether the endosomal processing pathway was also operative in murine TAP-proficient cells, Ltk (Fig. 4A) . In the same line, the presentation of the flag-SL8-K b fusion protein by TAP-proficient P815 cells was completely blocked by bafilomycin (Fig. 4B) . By contrast, the proteasome inhibitor lactacystin did not affect the reappearance of SL8:K b complexes after surface stripping. Lactacystin blocked, however, the presentation of SL8:K b complexes by TAP-proficient RMA cells expressing OVA in the cytoplasm (Fig. 4C) , indicating successful proteasome inhibition under the assay conditions used.
Aspartic-type cathepsins are involved in fusion protein processing
To further characterize endosomal proteases involved in fusion protein processing, cells were treated with inhibitors of either cysteine-type or aspartic-type cathepsins in acid wash/reappearance assays. Pepstatin A caused a ϳ50% inhibition of the B3Z response to RMA-S cells expressing the SL8-K d conjugate, suggesting that aspartic-type cathepsins contributed to processing, whereas no inhibition was observed using the potent membrane-permeable inhibitor of cathepsin S, E-64d (Fig. 5A) . Inhibition of cysteine proteases by leupeptin or cystatin also had only a minor effect on the (Fig. 5B) . Consistently, pepstatin A inhibited presentation of fusion proteins by fibroblasts deficient for the cysteine protease cathepsin B (Fig.  5C) . Furthermore, the presentation of peptide-K b/d fusion proteins was reduced in cathepsin D-deficient fibroblasts as compared with wild-type B6 and cathepsin B-deficient fibroblasts, whereas synthetic SL8 peptide was presented with equal efficiency (Fig. 5D ).
Targeting to processing compartments is independent of the cytoplasmic tail of MHC-I
Within the cytoplasmic tail of MHC-I molecules, a putative Tyrbased internalization motif (38) , Ser phosphorylation sites (39, 40), and Lys residues as acceptors for ubiquitin conjugation (41) have been implicated in the internalization of MHC-I from the cell surface, their targeting to endolysomal subcompartments, and recycling. To analyze the endosomal targeting of MHC-I-peptide fusion proteins in TAP-deficient, nonprofessional APCs, we either substituted the conserved tyrosine residue and potential phosphorylation sites of the cytoplasmic tail in K b and K d fusion proteins, or truncated the cytoplasmic tail to the residual amino acids RRRNTGG. Neither point mutation of serine/threonine and tyrosine residues (Fig. 6, A and C) , nor extensive truncation of the cytoplasmic tail (Fig. 6B) , nor fusion of the truncated tail with enhanced GFP (EGFP) impaired the presentation of peptide-fusion proteins by MCB6TAP Ϫ/Ϫ cells. As shown for RMA-S cells expressing SL8-K d (Y320P), SL8 presentation was blocked by folimycin, indicating that in the absence of the putative internalization motif the processing remained endosomal (Fig. 6C) . Likewise, Ltk Ϫ cells transfected with tail-truncated (RKKR)SL8-K d together with tailless K b were able to present SL8:K b complexes, and also this presentation was inhibited by folimycin (Fig. 6D) . This result suggests that not only the internalization of peptide-tagged MHC-I to endosomal processing compartments, but also the recycling of peptide-loaded K b are independent of sequence motifs in the cytoplasmic tail. Consistently, cathepsin B-deficient fibroblasts presented (RKKR)SL8-conjugated K d and K b fusion proteins with truncated tails, and also in this case pepstatin A markedly inhibited B3Z responses (Fig. 6E) . The presentation of tailless (RKKR)SL8-conjugated K d and K b fusion proteins could be blocked by filipin and chlorpromazine (data not shown), indicating that they were internalized from the cell surface into processing compartments.
SIINFEKL-loaded K b molecules appear in early and late endosomes
To investigate the intracellular trafficking of fusion proteins and the sites of SL8:K b complex formation, confocal laser-scanning microscopy was performed with MCB6TAP1 Ϫ/Ϫ cells transiently transfected with EGFP-tagged SL8-K d . EGFP appeared in a reticular ER-like staining as well as in punctate vesicular structures. We performed stainings of SL8-K d -EGFP-transfected cells with the early endosomal marker EEA-1, and the late endosomal markers CD63, LAMP-1, and VAMP-8, respectively. EGFP staining was colocalized, averaged over 8 -10 cells for which the costaining was quantitated, with ϳ10% of the vesicles staining for EEA-1, ϳ59% CD63 ϩ vesicles, ϳ22% LAMP-1 ϩ vesicles (Fig. 7A) , and ϳ35% VAMP-8 ϩ vesicles (data not shown), respectively. The Ab 25.D1-16 specifically recognizing SL8:K b complexes (27) predominantly stained vesicular structures (Fig. 7B ), in agreement with the formation of SL8:K b complexes in endosomes. We noted an overlap of the 25.D1-16 staining with ϳ5% of M6PR ϩ late endosomes (Fig. 7B ) and ϳ2% of EEA-1 ϩ early endosomes (data not shown).
Discussion
TAP-independent processing and presentation of proteins in the secretory pathway have been described (16 -19) ; however, little is known about processing compartments and proteases involved. A database of MHC ligands (42) lists 22 allelic MHC-I molecules that bind 25 different peptides derived from the ectodomains of other MHC-I allomorphs. We therefore reasoned that MHC-I molecules themselves might be well-suited carriers of peptide epitopes. As model Ags for endogenous membrane-associated proteins, we studied the processing of chimeric K b and K d MHC-I molecule proteins that contained the OVA-derived epitope SIINFEKL covalently linked to the ectodomain. We found that high levels of SL8:K b complexes were produced from most of the studied N-terminally extended SL8-MHC-I fusion proteins. Processing and presentation of fusion proteins were observed for TAP-deficient fibroblasts as well as TAP-deficient RMA-S T lymphoma cells, and are hence seen in different types of nonprofessional APCs. In accord with earlier reports (43) (44) (45) (46) (47) regarding the TAP-independent processing of soluble or bacterial-derived OVA, we found that TAP-deficient RMA-S and MCB6TAP
Ϫ/Ϫ cells did not significantly process and present exogenous OVA protein. We hypothesize that the comparatively much more efficient TAP-independent processing of membrane-bound Ags results from a spatial vicinity of recycling MHC-I molecules and epitope-carrying fusion proteins. Ag processing close to endosomal membranes may result in higher local peptide concentrations supporting peptide exchange by recycling MHC-I molecules.
Without exception, the generation of SL8:K b complexes from Nterminally extended K d and K b peptide fusions was blocked by acidophilic amines and inhibitors of the vacuolar proton pump. These pH-neutralizing drugs interfere with vesicular trafficking in the endosomal pathway as well as with the function of endolysosomal proteases (48 -50) . After acid stripping of the surface, neither newly synthesized fusion proteins exiting the ER nor autophagy of ER vesicles played a detectable role during subsequent SL8 epitope processing. By contrast, reagents inhibiting clathrin-dependent and -independent internalization clearly blocked the presentation of peptide-MHC-I fusion proteins. Endocytosis of MHC-I molecules by either mechanism has been described (35, (51) (52) (53) . Together, these findings suggest that SL8 was predominantly cleaved out of fusion proteins that were internalized from the plasma membrane into endosomal vesicles. Interestingly, this internalization did not require sequence motifs in the cytoplasmic tail of MHC-I because no loss in the presentation of K d -and K b -derived fusion proteins was observed after deletion of potential motifs either by sequence mutation or truncation of the cytoplasmic tail. Although a truncated tail was sufficient for MHC-I internalization in the human Jurkat T cell line (54), our results are in apparent conflict with a recent report showing that in dendritic cells, K b molecules with mutated tyrosine residue failed to cross-present exogenous soluble OVA and to produce SL8:K b complexes in late endosomes (38) . Dendritic cells may, however, use cell type-specific mechanisms to target K b to late endosomes that are dispensable for endosomal trafficking of MHC-I in transformed fibroblasts.
In the fusion protein SL8-K b , the SL8 peptide may bind to K b without endoproteolytic cleavage of the linker sequence, as suggested by former work using SL8-␤ 2 -microglobulin-K b and peptide-␤ 2 -microglobulin fusion proteins (55) (56) (57) . Our experiments do not exclude that a minor fraction of SL8-K b single-chain molecules in fact bound and presented SL8 in its unprocessed form; however, the similar sensitivity of SL8-K b and SL8-K d to internalization inhibitors and bafilomycin suggests that both conjugates underwent pH-dependent processing in endosomal vesicles. The MHC-I-associated ER chaperone tapasin was completely dispensable for the presentation of peptides processed out of MHC-I-derived chimeras. No evidence was also obtained for an involvement of the ER aminopeptidase ERAP1. As suggested by the partial blockade of MHC-I fusion protein presentation by a potent furin inhibitor, the proprotein convertase furin was involved in the processing if respective recognition sites were present. Furin is active in TGN vesicles that have an acidic pH ϳ5.0 (58, 59). The efficient blockade of Ag presentation by neutralizing agents is therefore not in conflict with furin contributing to MHC-I ectodomain processing.
In TAP-competent cells, antigenic peptides were previously shown to be processed out of membrane-associated proteins in a proteasome-dependent pathway (13) (14) (15) . In this study, SL8-MHC-I fusion proteins were efficiently processed and presented by various TAP-competent cells, including P815 and L cells (see Fig.  4 ), as well as HeLa and COS-7 cells (N. Tiwari and F. Momburg, unpublished results). Although the proteasome-specific inhibitor lactacystin exerted no detectable inhibition, proton pump inhibitors strongly suppressed the generation of the SL8 epitope from K b and K d fusion proteins. Thus, also in TAP-proficient cells, the vacuolar route rather than ER dislocation and cytosolic degradation seems to be an important source for antigenic peptides derived from glycoprotein ectodomains.
Cathepsin S and other cysteine proteases have been implicated in the cross-presentation of exogenous OVA administered through biodegradable microspheres to TAP-deficient dendritic cells (12) and through OVA-recombinant Escherichia coli to TAP-deficient macrophages (11) . In the present study, the inhibitor of aspartic proteases, pepstatin A, partially blocked B3Z responses to SL8-K d in reappearance assays, whereas various inhibitors of cathepsin S, B, and other cysteine proteases did not significantly affect presentation. Wild-type levels of Ag presentation by cathepsin B Ϫ/Ϫ fibroblasts suggested that the presence of this most abundant cysteine-type cathepsin was not critically required for processing. The inhibition of fusion protein presentation by pepstatin A in cathepsin B Ϫ/Ϫ cells and the reduced presentation in cathepsin D Ϫ/Ϫ cells, however, confirmed the importance of aspartic-type cathepsins for processing in these TAP-competent, nonprofessional APCs.
EGFP-tagged SL8-K d fusion proteins, which require processing and transfer of the SL8 epitope onto K b molecules for presentation, clearly colocalized with vesicles staining for late and early endosomal markers, supporting the presence of internalized fusion proteins throughout endosomal system, where they can be subjected to proteolytic degradation. The unique specificity of mAb 25.D1-16 furthermore allowed us to investigate by confocal microscopy intracellular compartments containing SL8:K b complexes. We observed partial costaining of the 25.D1-16 ϩ epitope with vesicles labeled for the late endosomal marker M6PR or the early endosomal marker EEA-1. This is in agreement with previous studies demonstrating the presence of MHC-I molecules in early endosomes and in multivesicular late endosomes, respectively, using different cell types for the analysis (9 -10, 60) . The low pH of late endosomes was reported to favor peptide exchange on recycling MHC-I molecules (9, 43, 58) . A larger fraction of 25.D1-16 ϩ vesicles, however, did not label for M6PR. Thus, it seems possible that recycling K b molecules were loaded with the SL8 peptide also in less acidic early endosomes. Alternatively, the 25.D1-16 staining of vesicles located in the cellular periphery may have resulted from the recycling into early endosomes of SL8:K b complexes that were assembled in late endosomes.
Taken together, evidence is provided for the targeting of epitope-carrying MHC-I-derived fusion proteins to endosomal vesicles for degradation, where a T cell epitope was cleaved out of various sequence contexts and loaded onto recycling K b molecules. This endosomal processing pathway functioned not only in TAP-deficient, but also in wild-type nonprofessional APCs. The vacuolar processing of membrane-associated Ags showed an unexpected efficacy. Therefore, membrane-associated proteins may be a source of TAP-independent Ags in tumor or virus-infected cells with down-modulated components of the proteasome/TAP pathway.
